KPC Pharmaceuticals,Inc.

¥8.86As of Sun 8 Nov 2026, 12:00 UTC
SSE:600422Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.71%)
Div yield 2.03%
ROE (4.03%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.17)
PE TTM —
TSR TTM (33.61%)
Mkt cap ¥6.707B
ROIC (5.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
20.36%
94.90%
Hold 7|6|12|7|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.13
0.13
0.13
(2.53%)
(6.59%)
1.05%
(0.52%)
Revenue¥M
827.5
825.8
808.0
822.2
5.31%
(0.24%)
(3.88%)
0.31%
Peers (US$1.005B)
Cap (US$)
PE
1.003B
—
996.4M
30.31x
1.008B
—
Capital
TTM
5Y
10Y
Leveragex
0.264
(0.148)
(0.106)
EBIT/Intx
1.203
0.335
0.310
Own earn%
(59.17)
(83.76)
(95.77)
Sh yield%
38.97
18.33
18.28
Owners
Insiders/Inst%
10.24
78.79
Short interest%
4.47
SBC / revenue%
4.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
21